PT Kimia Farma (Persero) Tbk (KAEF.JK)
IDR 600.0
(-0.83%)
IDR 600.0
(-0.83%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2504.06 Billion IDR | -21.18% |
| 2022 | 3176.94 Billion IDR | 18.06% |
| 2021 | 2690.96 Billion IDR | 9.57% |
| 2020 | 2455.82 Billion IDR | -13.8% |
| 2019 | 2849.1 Billion IDR | 57.78% |
| 2018 | 1805.73 Billion IDR | 51.44% |
| 2017 | 1192.34 Billion IDR | 23.26% |
| 2016 | 967.32 Billion IDR | 30.31% |
| 2015 | 742.31 Billion IDR | 7.99% |
| 2014 | 687.4 Billion IDR | 7.25% |
| 2013 | 640.9 Billion IDR | 20.83% |
| 2012 | 530.41 Billion IDR | 16.3% |
| 2011 | 456.06 Billion IDR | 17.95% |
| 2010 | 386.65 Billion IDR | -11.6% |
| 2009 | 437.4 Billion IDR | 5.42% |
| 2008 | 414.91 Billion IDR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 2098.37 Billion IDR | -13.44% |
| 2024 Q3 | 2032.55 Billion IDR | -3.55% |
| 2024 Q1 | 2424.25 Billion IDR | -3.19% |
| 2023 FY | 2504.06 Billion IDR | -21.18% |
| 2023 Q4 | 2504.06 Billion IDR | -28.59% |
| 2023 Q3 | 3506.6 Billion IDR | -5.51% |
| 2023 Q2 | 3711.22 Billion IDR | 7.15% |
| 2023 Q1 | 3463.72 Billion IDR | 9.03% |
| 2022 Q1 | 2669.25 Billion IDR | -0.81% |
| 2022 Q4 | 3176.94 Billion IDR | 12.77% |
| 2022 FY | 3176.94 Billion IDR | 18.06% |
| 2022 Q2 | 2619.69 Billion IDR | -1.86% |
| 2022 Q3 | 2817.17 Billion IDR | 7.54% |
| 2021 Q2 | 2489.2 Billion IDR | -1.38% |
| 2021 FY | 2690.96 Billion IDR | 9.57% |
| 2021 Q1 | 2524.07 Billion IDR | 2.78% |
| 2021 Q4 | 2690.96 Billion IDR | -23.62% |
| 2021 Q3 | 3523.26 Billion IDR | 41.54% |
| 2020 Q4 | 2455.82 Billion IDR | -17.51% |
| 2020 FY | 2455.82 Billion IDR | -13.8% |
| 2020 Q3 | 2976.95 Billion IDR | 1.11% |
| 2020 Q2 | 2944.17 Billion IDR | 7.95% |
| 2020 Q1 | 2727.23 Billion IDR | -4.28% |
| 2019 Q4 | 2849.1 Billion IDR | -1.11% |
| 2019 FY | 2849.1 Billion IDR | 57.78% |
| 2019 Q1 | 2428.53 Billion IDR | 34.49% |
| 2019 Q2 | 2652.1 Billion IDR | 9.21% |
| 2019 Q3 | 2881.04 Billion IDR | 8.63% |
| 2018 Q2 | 1539.55 Billion IDR | 12.3% |
| 2018 FY | 1805.73 Billion IDR | 51.44% |
| 2018 Q1 | 1370.98 Billion IDR | 14.98% |
| 2018 Q4 | 1805.73 Billion IDR | 2.63% |
| 2018 Q3 | 1759.38 Billion IDR | 14.28% |
| 2017 Q3 | 1206.76 Billion IDR | 12.31% |
| 2017 Q2 | 1074.52 Billion IDR | 11.79% |
| 2017 Q1 | 961.2 Billion IDR | -0.63% |
| 2017 FY | 1192.34 Billion IDR | 23.26% |
| 2017 Q4 | 1192.34 Billion IDR | -1.19% |
| 2016 Q3 | 885.91 Billion IDR | 1.67% |
| 2016 Q4 | 967.32 Billion IDR | 9.19% |
| 2016 Q1 | 792.65 Billion IDR | 6.78% |
| 2016 Q2 | 871.38 Billion IDR | 9.93% |
| 2016 FY | 967.32 Billion IDR | 30.31% |
| 2015 Q2 | 878.58 Billion IDR | 11.53% |
| 2015 Q1 | 787.76 Billion IDR | 14.6% |
| 2015 FY | 742.31 Billion IDR | 7.99% |
| 2015 Q3 | 820.91 Billion IDR | -6.56% |
| 2015 Q4 | 742.31 Billion IDR | -9.57% |
| 2014 Q4 | 687.4 Billion IDR | -8.06% |
| 2014 Q3 | 747.66 Billion IDR | -4.27% |
| 2014 Q2 | 780.99 Billion IDR | 10.77% |
| 2014 Q1 | 705.05 Billion IDR | 10.01% |
| 2014 FY | 687.4 Billion IDR | 7.25% |
| 2013 Q2 | 646.32 Billion IDR | 14.77% |
| 2013 Q4 | 640.9 Billion IDR | -2.39% |
| 2013 FY | 640.9 Billion IDR | 20.83% |
| 2013 Q3 | 656.62 Billion IDR | 1.59% |
| 2013 Q1 | 563.12 Billion IDR | 6.17% |
| 2012 Q3 | 583.98 Billion IDR | -6.38% |
| 2012 Q4 | 530.41 Billion IDR | -9.17% |
| 2012 Q1 | 591.21 Billion IDR | 29.63% |
| 2012 FY | 530.41 Billion IDR | 16.3% |
| 2012 Q2 | 623.75 Billion IDR | 5.5% |
| 2011 FY | 456.06 Billion IDR | 17.95% |
| 2011 Q4 | 456.06 Billion IDR | 0.0% |
| 2010 FY | 386.65 Billion IDR | -11.6% |
| 2009 FY | 437.4 Billion IDR | 5.42% |
| 2008 FY | 414.91 Billion IDR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 3843.44 Billion IDR | 34.849% |
| PT Itama Ranoraya Tbk | 133.25 Billion IDR | -1779.098% |
| PT Millennium Pharmacon International Tbk | 535.87 Billion IDR | -367.286% |
| PT Soho Global Health Tbk | 1390.85 Billion IDR | -80.038% |